Funding News for global health researchers from the Fogarty International Center at NIH

Funding opportunities and news for global health researchers from the Fogarty International Center at the U.S. National Institutes of Health. On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Top NIH Funding News NIH funding news that may be relevant to global health researchers: Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates on or After January 25, 2022 - New Grant Application. Instructions Now Available. (NOT-OD-22-018) Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic (NOT-OD-22-046) Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils (NOT-OD-22-047) Upcoming Deadlines for Fogarty Funding Opportunities International Research Scientist Development Award (IRSDA) Application deadline: March 9, 2022 Chronic, Noncommunicable Diseases and Disorders Research Training Application deadline: July 13, 2022 Upcoming deadlines for all Fogarty funding opportunities Funding Opportunities NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply: PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional (RFA-FD-22-012) Application Receipt Date: March 31, 2022 Cutaneous Pharmacokinetics (PK) Based Approaches to Demonstrate Bioequivalence of Topical Products (U01) Clinical Trial Required (RFA-FD-22-017) Application Receipt Date: March 31, 2022, Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed (PAR-22-087) Application Receipt Date: April 1, 2022 Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) (RFA-AG-23-009) Application Receipt Date: June 14, 2022 Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) (RFA-MH-22-135) Application Receipt Date: October 15, 2022 Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) (RFA-MH-22-136) Application Receipt Date: October 15, 2022 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) (PAR-22-093)  Application Receipt Date: November 12, 2024 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) (PAR-22-094) Application Receipt Date: November 12, 2024 Other Funding News NIH Notices of Special Interest (NOSIs) related to opportunities on which Fogarty is a funding partner: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-22-026) Expiration Date: March 17, 2022 Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging (NOT-AG-22-005) Expiration Date: April 29, 2022 Pain-Focused Administrative Supplements for NINDS Grants that are Not Focused on Pain Research (NOT-NS-22-053) Expiration Date: June 2, 2022 NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional) (NOT-MH-22-060) Expiration Date:  April 2, 2024 NIDDK National Research Service Award (NRSA) T32 Diversity Administrative Supplement (NOT-DK-21-016) Expiration Date: May 16, 2024 National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program for Pre- and Postdoctoral Candidates from Diverse Backgrounds (NOT-AT-21-013) Expiration Date: July 2, 2024 NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers: NINDS mission relevant Pain Research (NOT-NS-22-050) Expiration Date: May 8, 2022 Migraine and Headache Research (NOT-NS-22-051) Expiration Date: May 8, 2022 NCCIH High Priority Pain Research (NOT-AT-22-007) Expiration Date: December 15, 2022 Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases (NOT-AR-22-012) Expiration Date:  January 8, 2023 Advancing Research Needed to Develop a Universal Influenza Vaccine (NOT-AI-22-013) Expiration Date: January 8, 2025 Pediatric COVID-19 and Respiratory Viral Co-infection (NOT-HL-22-004) Expiration Date: September 8, 2025 Advancing Innovative Non-invasive Physiologic Monitoring o Improve Fetal Assessment (NOT-HD-21-053) Expiration Date: May 8, 2024 Notices of intent to publish NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply: HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) (NOT-NS-22-040) Estimated Publication Date: February 1, 2022 HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) (NOT-NS-22-063) Estimated Publication Date: February 1, 2022 HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes & Cells (U19 Clinical Trial Not Allowed) (NOT-NS-22-065) Estimated Publication Date: February 1, 2022 Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (NOT-CA-22-027) Estimated Publication Date: February 3, 2022 Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) (NOT-CA-22-026) Estimated Publication Date: February 14, 2022 Biomedical-engineering Partnership with Industry (U01 Clinical Trial Not Allowed) (NOT-EB-21-024) Estimated Publication Date: February 26, 2022 Non-NIH funding opportunities that may be of interest to global health researchers: Call for proposals on infectious diseases (including antimicrobial resistance) and cancer research   from e-ASIA Joint Research Program (the e-ASIA JRP).  Application deadline: March 30, 2022 Request for Information: Request for Information (RFI): Inviting Comments and Suggestions on Updating the Strategic Plan for Trans-NIH Research to Cure Hepatitis B (NOT-AI-22-018) Featured Fogarty News and Information Focus: Global cancer research supported by the National Cancer Institute (NCI) View all Fogarty news View and subscribe to Fogarty's Global Health Matters e-newsletter Featured NIH News Landmark COVID-19 vaccine trial in sub-Saharan Africa is the first to study the efficacy of MRNA COVID-19 vaccines in people living with HIV HVTN/Fred Hutchinson Cancer Research Center news release, Dec 13, 2021 NIH COVID-19 Funding and News NIH COVID-19 funding opportunities NIH COVID-19 information for grant applicants and grant recipients COVID-19 news, funding and resources for global health researchers compiled by Fogarty Events Training and events for global health researchers: January 4, 2022: COVID: Then, Now, and the Future / The global challenge: COVID and Future Pandemics    Dr. Anthony Fauci, NIAID director, and Dr. Roger Glass, Fogarty director give this lecture, part of NIH's annual Demystifying Medicine course More Information View all Fogarty funding opportunities Search all NIH funding opportunities and notices Subscribe to NIH Guide for Grants and Contracts weekly emails   STAY CONNECTED:   SUBSCRIBER SERVICES:  Manage Preferences  |  Unsubscribe You are subscribed to receive Fogarty Funding Opportunities email updates at ignoble.experiment@arconati.us. The Fogarty International Center, the international component of the U.S. National Institutes of Health, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships. We encourage you to forward this to colleagues who may find it of interest. This email was sent to ignoble.experiment@arconati.us using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH · National Institutes of Health · Bethesda, MD 20892 · (301) 496-2075 · ficinfo@mail.nih.gov